SkinBioTherapeutics Plc
SBTX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £4,779 | £1,237 | £801 | £2,841 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £1,411 | £502 | £341 | £165 |
| Inventory | £800 | £828 | £472 | £47 |
| Other Curr. Assets | £0 | £0 | £0 | £238 |
| Total Curr. Assets | £7,108 | £2,567 | £1,671 | £3,290 |
| Property Plant & Equip (Net) | £728 | £478 | £116 | £160 |
| Goodwill | £2,420 | £0 | £2,038 | £0 |
| Intangibles | £1,869 | £4,252 | £1,389 | £761 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £5,017 | £4,730 | £3,544 | £922 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £12,126 | £7,297 | £5,215 | £4,211 |
| Liabilities | – | – | – | – |
| Payables | £513 | £723 | £281 | £463 |
| Short-Term Debt | £112 | £50 | £740 | £37 |
| Tax Payable | £155 | £0 | £65 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £697 | £450 | £676 | -£37 |
| Total Curr. Liab. | £1,469 | £1,432 | £1,805 | £501 |
| LT Debt | £600 | £957 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £356 | £151 | £151 | £0 |
| Other NC Liab. | £0 | £250 | £250 | £0 |
| Total NC Liab. | £1,237 | £1,377 | £440 | £60 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £393 | £70 | £79 | £97 |
| Total Liabilities | £2,707 | £2,809 | £2,245 | £560 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £2,588 | £2,284 | £2,023 | £1,904 |
| Retained Earnings | -£14,695 | -£15,033 | -£13,999 | -£12,458 |
| AOCI | £439 | £439 | £439 | £439 |
| Other Equity | £0 | £0 | £0 | £0 |
| Total Equity | £9,419 | £4,488 | £2,970 | £3,651 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £12,126 | £7,297 | £5,215 | £4,211 |
| Net Debt | -£4,067 | -£230 | -£61 | -£2,803 |